newsfilter
← Latest News
GlobeNewswire·

Allakos Appoints Neil Graham to its Board of Directors

SAN CARLOS, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells